Pfizer board to consider audited financial results & dividend

26 Apr 2018 Evaluate

Pfizer has informed that a meeting of the Board of Directors of the Company is scheduled to be held on May 07, 2018, to consider and take on record the Audited Financial Results of the Company for the financial year ended March 31, 2018. At the said meeting, the Board of Directors will also consider recommendation of dividend, if any, for the financial year ended March 31, 2018. Further, the Trading Window for trading in the Equity shares of the Company will be closed from April 27, 2018 to May 09, 2018.

The above information is a part of company’s filings submitted to BSE.

Pfizer Share Price

5301.55 79.50 (1.52%)
25-Nov-2024 10:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.95
Dr. Reddys Lab 1216.55
Cipla 1498.60
Lupin 2093.25
Zydus Lifesciences 956.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.